Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

about

Cellular bioenergetics is impaired in patients with chronic fatigue syndrome.

P2860

Q42517358-F03EB236-5C99-4C84-AEB5-5802BD6E480F

P2860

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

Item

http://www.wikidata.org/entity/Q36311088

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

@ast

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

@en

type

Item

label

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

@ast

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

@en

prefLabel

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

@ast

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

@en

P1476

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome

@en

P2093

Charlotte V Y Knowles

http://www.w3.org/2001/XMLSchema#string

Elardus Erasmus

http://www.w3.org/2001/XMLSchema#string

Etresia van Dyk

http://www.w3.org/2001/XMLSchema#string

Joanna L Elson

http://www.w3.org/2001/XMLSchema#string

Julia L Newton

http://www.w3.org/2001/XMLSchema#string

Robert W Taylor

http://www.w3.org/2001/XMLSchema#string

Shereen Al-Ali

http://www.w3.org/2001/XMLSchema#string

Wan-Fai Ng

http://www.w3.org/2001/XMLSchema#string

P2860

Abnormalities of AMPK activation and glucose uptake in cultured skeletal muscle cells from individuals with chronic fatigue syndrome

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease

Late-onset mitochondrial myopathy with dystrophic changes due to a G7497A mutation in the mitochondrial tRNA(Ser(UCN)) gene.

mtDNA nt13708A variant increases the risk of multiple sclerosis.

Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation.

Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations

Decrease of 3243 A-->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study.

mtDNA Variation and Analysis Using Mitomap and Mitomaster

Characterization of mtDNA variation in a cohort of South African paediatric patients with mitochondrial disease.

P2888

s12881-017-0387-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12881-017-0387-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizna M Schoeman

Francois van der Westhuizen

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084250392

http://www.w3.org/2001/XMLSchema#string

P698

28302057

http://www.w3.org/2001/XMLSchema#string

P932

5356238

http://www.w3.org/2001/XMLSchema#string

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

about

P2860

P2860

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932